# A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

> **NCT07094204** · PHASE1 · RECRUITING · sponsor: **Astellas Pharma Inc** · enrollment: 364 (estimated)

## Conditions studied

- Solid Tumor
- Non-Small-Cell Lung Cancer
- Pancreatic Ductal Adenocarcinoma
- Colorectal Cancer

## Interventions

- **DRUG:** ASP5834
- **DRUG:** panitumumab

## Key facts

- **NCT ID:** NCT07094204
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-25
- **Primary completion:** 2028-11-30
- **Final completion:** 2029-04-30
- **Target enrollment:** 364 (ESTIMATED)
- **Last updated:** 2026-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07094204

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07094204, "A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07094204. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*